Catalyst Biosciences, Inc. - Special Call Transcript
Good afternoon, everyone, and thank you for attending our KOL event today hosted by Catalyst Biosciences on next generation Factor VIIa Marzeptacog alfa activated or MarzAA, in patients with bleeding disorders. Today, we'll be hearing from 2 hemophilia experts in the field of hemophilia, Dr. Robert Klamroth and Dr. Steven Pipe. We will also be hearing from the senior members of the management team, Dr. Howard Levy, our Chief Medical Officer; Jeff Landau, VP of Business Development, Grant Blouse, VP of translational research; Fletcher Payne, whose last name takes on particular significance today, our Chief Financial Officer; and Nassim Usman. With that, I will open the floor to Dr. Nassim Usman.
Great. Thank you everyone for attending today, and welcome to our MarzAA KOL luncheon. I'm very pleased that we have a great turnout, and I hope you're going to learn a lot from our 2 speakers today who have been working in the hemophilia field for a long time and other rare
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |